Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism

Abstract In efforts to evaluate potential biomarkers and drug targets for Neurofibromatosis Type I (NF1) we utilized affinity mass spectrometry and global proteomics to investigate how variation within and loss of NF1 affect immortalized human Schwann cells. We used Strep tagged mNf1 cDNAs (both wil...

Full description

Saved in:
Bibliographic Details
Main Authors: Christian X Fay, Elizabeth R.M. Zunica, Elias Awad, William Bradley, Cameron Church, Jian Liu, Hui Liu, David K. Crossman, James A. Mobley, John P. Kirwan, Christopher L. Axelrod, Erik Westin, Robert A. Kesterson, Deeann Wallis
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-84493-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571894355722240
author Christian X Fay
Elizabeth R.M. Zunica
Elias Awad
William Bradley
Cameron Church
Jian Liu
Hui Liu
David K. Crossman
James A. Mobley
John P. Kirwan
Christopher L. Axelrod
Erik Westin
Robert A. Kesterson
Deeann Wallis
author_facet Christian X Fay
Elizabeth R.M. Zunica
Elias Awad
William Bradley
Cameron Church
Jian Liu
Hui Liu
David K. Crossman
James A. Mobley
John P. Kirwan
Christopher L. Axelrod
Erik Westin
Robert A. Kesterson
Deeann Wallis
author_sort Christian X Fay
collection DOAJ
description Abstract In efforts to evaluate potential biomarkers and drug targets for Neurofibromatosis Type I (NF1) we utilized affinity mass spectrometry and global proteomics to investigate how variation within and loss of NF1 affect immortalized human Schwann cells. We used Strep tagged mNf1 cDNAs (both wild type (WT) and variant) to affinity purity NF1 Protein-Protein interactors (PPIs) from the Schwann cells. We were able to identify 98 PPIs and show that some of these PPIs bind differentially to variant proteins. Next, we evaluated global proteomes. We identified over 1900 proteins in immortalized human Schwann cells both with and without NF1 expression. We identified 148 proteins with differential expression levels based on genotype. Following Ingenuity Pathway analysis (IPA) we found multiple pathways were altered including decreases in “oxidative phosphorylation,” increases in “mitochondrial dysfunction”, and “glycolysis”, as well as changes in “Myelination Signaling Pathway.” When we evaluated the proteome of NF1 null cells stably transfected with tagged mNf1 cDNAs we again identified an overall trend of metabolic differences pertaining to “oxidative phosphorylation”, “mitochondria dysfunction”, and “glycolysis” in the variant cDNA expressing cells. We then validated differential expression of the following proteins: LAMC1, CYB5R3, and SOD2 that are observed in the altered pathways. Finally, consistent with our proteomics findings, we show that NF1 is required to maintain mitochondrial respiratory function in Schwann cells by stabilizing NADH-linked oxidative phosphorylation and electron transfer. Taken together, these data indicate that NF1 plays a significant role in mitochondrial metabolism that results in proteomic changes in Schwann cells and may serve as a future drug target.
format Article
id doaj-art-e2a40d8a127e470f8a8125059b3993ea
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e2a40d8a127e470f8a8125059b3993ea2025-02-02T12:16:12ZengNature PortfolioScientific Reports2045-23222025-01-0115111810.1038/s41598-024-84493-yGlobal proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolismChristian X Fay0Elizabeth R.M. Zunica1Elias Awad2William Bradley3Cameron Church4Jian Liu5Hui Liu6David K. Crossman7James A. Mobley8John P. Kirwan9Christopher L. Axelrod10Erik Westin11Robert A. Kesterson12Deeann Wallis13Department of Genetics, The University of Alabama at BirminghamPennington Biomedical Research CenterDepartment of Genetics, The University of Alabama at BirminghamDepartment of Genetics, The University of Alabama at BirminghamDepartment of Genetics, The University of Alabama at BirminghamDepartment of Genetics, The University of Alabama at BirminghamDepartment of Genetics, The University of Alabama at BirminghamDepartment of Genetics, The University of Alabama at BirminghamDepartment of Anesthesiology and Perioperative Medicine, The University of Alabama at BirminghamPennington Biomedical Research CenterPennington Biomedical Research CenterPennington Biomedical Research CenterPennington Biomedical Research CenterDepartment of Genetics, The University of Alabama at BirminghamAbstract In efforts to evaluate potential biomarkers and drug targets for Neurofibromatosis Type I (NF1) we utilized affinity mass spectrometry and global proteomics to investigate how variation within and loss of NF1 affect immortalized human Schwann cells. We used Strep tagged mNf1 cDNAs (both wild type (WT) and variant) to affinity purity NF1 Protein-Protein interactors (PPIs) from the Schwann cells. We were able to identify 98 PPIs and show that some of these PPIs bind differentially to variant proteins. Next, we evaluated global proteomes. We identified over 1900 proteins in immortalized human Schwann cells both with and without NF1 expression. We identified 148 proteins with differential expression levels based on genotype. Following Ingenuity Pathway analysis (IPA) we found multiple pathways were altered including decreases in “oxidative phosphorylation,” increases in “mitochondrial dysfunction”, and “glycolysis”, as well as changes in “Myelination Signaling Pathway.” When we evaluated the proteome of NF1 null cells stably transfected with tagged mNf1 cDNAs we again identified an overall trend of metabolic differences pertaining to “oxidative phosphorylation”, “mitochondria dysfunction”, and “glycolysis” in the variant cDNA expressing cells. We then validated differential expression of the following proteins: LAMC1, CYB5R3, and SOD2 that are observed in the altered pathways. Finally, consistent with our proteomics findings, we show that NF1 is required to maintain mitochondrial respiratory function in Schwann cells by stabilizing NADH-linked oxidative phosphorylation and electron transfer. Taken together, these data indicate that NF1 plays a significant role in mitochondrial metabolism that results in proteomic changes in Schwann cells and may serve as a future drug target.https://doi.org/10.1038/s41598-024-84493-y
spellingShingle Christian X Fay
Elizabeth R.M. Zunica
Elias Awad
William Bradley
Cameron Church
Jian Liu
Hui Liu
David K. Crossman
James A. Mobley
John P. Kirwan
Christopher L. Axelrod
Erik Westin
Robert A. Kesterson
Deeann Wallis
Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
Scientific Reports
title Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
title_full Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
title_fullStr Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
title_full_unstemmed Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
title_short Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
title_sort global proteomics and affinity mass spectrometry analysis of human schwann cells indicates that variation in and loss of neurofibromin nf1 alters protein expression and cellular and mitochondrial metabolism
url https://doi.org/10.1038/s41598-024-84493-y
work_keys_str_mv AT christianxfay globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT elizabethrmzunica globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT eliasawad globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT williambradley globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT cameronchurch globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT jianliu globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT huiliu globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT davidkcrossman globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT jamesamobley globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT johnpkirwan globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT christopherlaxelrod globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT erikwestin globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT robertakesterson globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism
AT deeannwallis globalproteomicsandaffinitymassspectrometryanalysisofhumanschwanncellsindicatesthatvariationinandlossofneurofibrominnf1altersproteinexpressionandcellularandmitochondrialmetabolism